Vendor, Columbia, MD
Intralytix Inc.
UEI HXUNCLKMHAP4, CAGE 4GXB8
2 awards and $178,777 obligated between January 22, 2024 and December 16, 2025, 50% under full and open competition, against 3.5 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $178,777 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Not Available for Competition | 1 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W911QY25C0015Definitive Contract, February 13, 2025, Full and Open Competition, 1 offers | W6QK ACC-APG NatickDepartment of the Army | Broad Agency Announcement to Have Stable Dry Formulation of a Safe Phage Preparation That Possesses Strong Antimicrobial Efficacy Against FoNAICS 541714, PSC AC32 | $178,777 |
| 75N93021C00034Definitive Contract, January 22, 2024, Not Available for Competition, 6 offers | National Institutes of Health NiaidNational Institutes of Health | Incorporate FAR Language to the Contract.NAICS 541714, PSC AN12 | $0 |
- Places of performance
- Maryland
- Product and service codes
- AC32 National Defense R&D Services; Defense-Related Activities; Applied ResearchAN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 8 across 2 awards